Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Wuxi Biologics Cayman Inc ADR (WXXWY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.3900 +10.98%
on 03/25/19
21.4500 -4.85%
on 04/16/19
-0.3190 (-1.54%)
since 03/18/19
3-Month
15.1600 +34.63%
on 01/22/19
21.4500 -4.85%
on 04/16/19
+5.0400 (+32.79%)
since 01/18/19
52-Week
11.5600 +76.56%
on 01/03/19
24.7800 -17.64%
on 06/07/18
+1.5200 (+8.05%)
since 04/18/18

Most Recent Stories

More News
WuXi Biologics and I-Mab Biopharma Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs

SHANGHAI , April 16, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...

WXXWY : 20.4100 (-3.50%)
WuXi Biologics and NBE-Therapeutics Announce Comprehensive ADC Development and Manufacturing Partnership

SHANGHAI and BASEL, Switzerland , April 8, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform...

WXXWY : 20.4100 (-3.50%)
WuXi Biologics Wins 2019 CMO Leadership Awards in All Six Core Categories

SHANGHAI and NEW YORK , April 3, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for...

WXXWY : 20.4100 (-3.50%)
WuXi Biologics Receives "Asia's Best CMO of 2018" Award from IMAPAC

SHANGHAI and SINGAPORE , March 25, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (Stock Code: 2269.HK), a leading global open-access biologics technology platform company offering end-to-end...

WXXWY : 20.4100 (-3.50%)
WuXi Biologics Receives EMA GMP Certificates

SHANGHAI and WUXI, China , March 19, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end...

WXXWY : 20.4100 (-3.50%)
WuXi Biologics Continues to Deliver Record Results

HONG KONG , March 18, 2019 /PRNewswire/ -- WuXi Biologics (Cayman) Inc. ( " WuXi Biologics "  or " the Group ",  stock code: 2269.HK) , a leading global open-access...

WXXWY : 20.4100 (-3.50%)
WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

SHANGHAI and CRANBURY, N.J. , Feb. 11, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions...

WXXWY : 20.4100 (-3.50%)
WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland

DUNDALK, Ireland and SHANGHAI , April 30, 2018 /PRNewswire/ -- An Taoiseach Leo Varadkar , Prime Minister of Ireland today announced that WuXi Biologics, a Hong Kong -listed (2269.HK)...

WXXWY : 20.4100 (-3.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade WXXWY with:

Key Turning Points

2nd Resistance Point 20.6533
1st Resistance Point 20.5317
Last Price 20.4100
1st Support Level 20.2667
2nd Support Level 20.1233

See More

52-Week High 24.7800
Last Price 20.4100
Fibonacci 61.8% 19.7300
Fibonacci 50% 18.1700
Fibonacci 38.2% 16.6100
52-Week Low 11.5600

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar